Literature DB >> 14515006

The management of well-differentiated thyroid cancer with end-stage renal disease.

Tien-Hsiang Wang1, Chen-Hsen Lee, Ling-Ming Tseng, Ren-Hsieng Liu.   

Abstract

The occurrence of thyroid cancer in patients with endstage renal disease is rare. We have had the experience of treating two such patients. The problems, encountered in these patients, were the enlarged parathyroid glands at the time of total thyroidectomy and the treatment of these patients with 131I when the biologic halflife of radioiodine increases after hemodialysis. Both patients were treated by total thyroidectomy and postoperative administration of 131I, either empirically or dosimetrically, and are living and well, 9 yr and 7 yr after operations, respectively.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14515006     DOI： 10.1385/ENDO:21:3:227

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  13 in total

1.  Tertiary hyperparathyroidism after renal transplantation.

Authors:  J T Fang; C K Chuang; S H Chu; L B Jeng; C C Huang
Journal:  Transplant Proc       Date:  1996-06       Impact factor: 1.066

Review 2.  Cancer in end-stage renal disease: potential factors involved -editorial-.

Authors:  S Vamvakas; U Bahner; A Heidland
Journal:  Am J Nephrol       Date:  1998       Impact factor: 3.754

3.  Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis.

Authors:  C Daumerie; S Vynckier; J Caussin; M Jadoul; J P Squifflet; N de Patoul; A Wambersie
Journal:  Thyroid       Date:  1996-08       Impact factor: 6.568

4.  Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.

Authors:  C H Wallfelt; R Larsson; E Gylfe; S Ljunghall; J Rastad; G Akerström
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 5.  The pathogenesis of parathyroid gland hyperplasia in chronic renal failure.

Authors:  T B Drüeke
Journal:  Kidney Int       Date:  1995-07       Impact factor: 10.612

6.  131I treatment of thyroid papillary carcinoma in a patient with renal failure.

Authors:  D W Morrish; L J Filipow; A J McEwan; R Schmidt; K R Murland; C von Westarp; K B Betcher
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

7.  Cellular proliferation and secretion in secondary hyperparathyroidism during renal failure.

Authors:  T Fujisaki; M Hida; S Hiraga; R Y Osamura
Journal:  Nephron       Date:  1997       Impact factor: 2.847

8.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Authors:  P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

9.  Tertiary hyperparathyroidism after renal transplantation: surgical strategy.

Authors:  M S Kilgo; J D Pirsch; T F Warner; J R Starling
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

10.  Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis.

Authors:  A M Mello; R Isaacs; J Petersen; S Kronenberger; I R McDougall
Journal:  Clin Nucl Med       Date:  1994-09       Impact factor: 7.794
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.